Fabino Life Sciences Ltd - 543444 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2022 dated January 11, 2023 received from M/s Bigshare Services Private Limited, the Registrar and Share Transfer Agent of the Company. Fabino Life Sciences Ltd - 543444 - Board Meeting Outcome for Revised Outcome Of Board Meeting & Submission Of Unaudited Financial Results For Half Year Ended September 30, 2022
In continuation of our letter dated November 02, 2022, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Unaudited Financial Results set out in compliance with Accounting Standards (AS) for the Half Year ended September 30, 2022 , duly approved by the Board of Directors of the Company in their meeting held on November 09, 2022 together with Statement of Assets and Liabilities, Cash Flow and Limited Review Report thereon are enclosed. Fabino Life Sciences Ltd - 543444 - Board Meeting Outcome for Outcome Of Board Meeting - Submission Of Unaudited Financial Results For Half Year Ended September 30, 2022
In continuation of our letter dated November 02, 2022, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Unaudited Financial Results set out in compliance with Accounting Standards (AS) for the Half Year ended September 30, 2022 , duly approved by the Board of Directors of the Company in their meeting held today i.e. November 09, 2022 together with Statement of Assets and Liabilities, Cash Flow and Limited Review Report thereon are enclosed. Fabino Life Sciences Ltd - 543444 - Board Meeting Intimation for Intimation Of Board Meeting For Consideration And Approval Of Unaudited Financial Results For Half Year Ended September 30, 2022 And Closure Of Trading Window
Fabino Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 ,inter alia, to consider and approve In pursuant to Regulation 29(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 this is to inform you, that a meeting of the Board of Directors of Fabino Life Sciences Limited is scheduled to be held on Wednesday, November 09, 2022 at Registered Office of the Company at 105, Plot No 12, Barodia Tower, 1st Floor, D Block, Central Market, Prashant Vihar, New Delhi-110085, inter-alia to discuss and approve among other items, the Unaudited Financial Results and Statement of Assets and Liabilities for half year ended September 30, 2022. Further, in terms of the Code of Conduct of Company adopted under SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window for dealing in the securities of the Company is already closed and shall open 48 hours after conclusion of the Board Meeting. Fabino Life Sciences Ltd - 543444 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022 dated October 18, 2022 received from M/s Bigshare Services Private Limited, the Registrar and Share Transfer Agent of the Company. Fabino Life Sciences Ltd - 543444 - Closure of Trading Window
We hereby inform you that in terms of Company's Code for prevention of Insider Trading framed under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company would remain close from Saturday, 1st October, 2022 till the completion of 48 hours after announcement of the Unaudited Financial Results of half year ended 30th September, 2022; for Designated persons of the Company including their immediate relatives. The date of Board meeting to be held for the consideration and approval of the Financial Results of the above mentioned period will be communicated in due course of time. Fabino Life Sciences Ltd - 543444 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Scrutinizer''s Report on e-voting and voting at the 11th Annual General Meeting (''AGM'') of the Company held on Thursday, September 22, 2022 is enclosed. Fabino Life Sciences Ltd - 543444 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, Annexed herewith is proceedings of 11th Annual General Meeting (AGM) of the Company held on 22 September, 2022 at 105, 1st Floor, Barodia Tower, Plot No 12, D Block Central Market, Prashant Vihar, New Delhi - 110085 as Annexure-I. Fabino Life Sciences Ltd - 543444 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, Annexed herewith is proceedings of 11th Annual General Meeting (AGM) of the Company held on 22 September, 2022 at 105, 1st Floor, Barodia Tower, Plot No 12, D Block Central Market, Prashant Vihar, New Delhi - 110085 as Annexure-I. Fabino Life Sciences Ltd - 543444 - Reg. 34 (1) Annual Report.
Enclosed is the Annual Report for the Financial Year ended March 31, 2022 of Fabino Life Science Limited